Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Pesticides/Agrochemicals
  4. /Dhanuka Agritech Ltd
MomentumDeep Value

Dhanuka Agritech Ltd: Is It a Deep Value Opportunity?

Weak

As of May 17, 2026, Dhanuka Agritech Ltd (Pesticides/Agrochemicals) has a deep value score of 34/100 (rated Weak). 1Y return vs Nifty 500: -24%.

Dhanuka Agritech Ltd Key Facts

PE Ratio
16.7x
Market Cap
₹4,884 Cr
Value Score
34/100
Margin of Safety
-60%
PAT Growth YoY
-27%
Revenue Growth YoY
-8%
OPM
14.0%
PE: Near TroughFalling Knife

What's Happening

🔻Earnings declining and PE falling — fundamentals deteriorating
💪Debt reduced 57% YoY — balance sheet strengthening
👔Promoter stake down 0.6% this quarter
💰Trading 60% above estimated fair value — significant premium

Earnings Acceleration Triggers

1. New Product Or Brand Launch
9-month periodMEDIUM
2. Operating Leverage Inflection
FY27MEDIUM
3. Regulatory Approval Or License Win
Q1 FY27MEDIUM

Key Risks

1. Significantly extended rainfall and potential El Nino impact on Kharif season
HIGH
2. Ban on biostimulants led to a ₹49 Cr impact on 9-month sales
MEDIUM
3. China ending export rebates on technicals may increase prices
LOW

Sector-Specific Signals

Herbicides % of Turnover37%
South India Revenue Share34%
Sales Returns (Q3)₹72 Cr-₹2 Cr
Biostimulant Regulatory Impact (9M)₹49 Cr

Key Numbers

PAT Growth YoY
-27%
Inflection Down
Revenue YoY
-8%
Inflection Down
Operating Margin
14.0%
-300 bps YoY
PE Ratio
16.7
PEG Ratio
1.03
Current Price
₹1,084
Dividend Yield
0.18%
3Y PAT CAGR
+12%
Market Cap
4.9K Cr
Valuation
Significantly Overvalued

Why Are Dhanuka Agritech Ltd's Earnings Accelerating?

Based on Q3 FY26 earnings • Updated Apr 18, 2026

New Product Or Brand Launch

Expected: 9-month periodMEDIUM confidence

What: Product Count: 3 products

“In 9-month period, we have launched one is Dinkar, one is Melody and one is Verdour.”

Operating Leverage Inflection

Expected: FY27MEDIUM confidence

What: Capacity Utilization: 80%

Impact: EBITDA Positive

“Definitely, there would be an improvement in the margin structure for the products once the manufacturing moves to India, absolutely.”

Regulatory Approval Or License Win

Expected: Q1 FY27MEDIUM confidence

What: Product Approvals: 3 products

“But yes, we are tracking our approvals and we are hopeful of getting out of our, at least 3 products approval in this quarter, so that we can launch by Q1 ending.”

What Are the Key Risks for Dhanuka Agritech Ltd?

Earnings deceleration risks from management commentary

Significantly extended rainfall and potential El Nino impact on Kharif season

HIGH

Trigger: Weather patterns delayed harvesting and reduced agrochemical application.

Management view: Monitoring IMD forecasts; focusing on Rabi season recovery.

Monitor: climate

Ban on biostimulants led to a ₹49 Cr impact on 9-month sales

MEDIUM

Trigger: New government guidelines required fresh clearances for biostimulant products.

Impact: PAT impact: ₹49 Cr revenue hit

Management view: Applied for proprietary clearances; expecting 3 approvals by Q4 end.

Monitor: regulatory

China ending export rebates on technicals may increase prices

LOW

Trigger: Internal approach by China to reduce export incentives.

Management view: Passing on increased costs downstream; sourcing some products like Glufosinate from India.

Monitor: commodity

What Is Dhanuka Agritech Ltd's Management Saying?

Key quotes from recent conference calls

“So, first question, I think, on the PPT, you have mentioned that you're expecting a flattish revenue performance in FY '26. [Previous Revenue Growth guidance]”
“We are working for making Dahej operations EBITDA positive in FY'27 and try to reach 80% capacity utilization of the existing plant. [Initiative: Dahej Plant Scale-up]”
“Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. [Risk (climate): HIGH]”
“Product under regulatory changes in this category... 9 month is the impact of Rs. 49 crore on account of these four products biostimulant stock sale basically. [Risk (regulatory): MEDIUM]”

What Did Dhanuka Agritech Ltd Report This Quarter?

Headline numbers from the latest earnings call

Revenue

₹409.92 Cr

YoY -7.9%QoQ -31.5%

Why: Agrochemical demand remained weak due to stressed demand drivers, weather issues, and low crop prices leading to industry-wide volume decline.

Revenue was significantly impacted by sharp demand declines in South and West India.

EBITDA

₹58.66 Cr

YoY -22.4%Margin 14.3%

Why: The decline was driven by lower top-line realizations and the impact of two straight negative quarters.

Margins were pressured by weak demand and extended rainfall delaying farmer purchases.

PAT

₹40 Cr

YoY -27.3%QoQ -57.4%

Why: Lower farm incomes reduced spending on crop production products, impacting domestic sales and overall profitability.

Management described the two straight negative quarters as a blemish on an otherwise decent performance.

Other Highlights

• Commercialized second product from Dahej plant in Q3 FY'26.

• Net economic benefit from Bayer molecules was ₹6 Cr in Q3.

• Cash on books and liquid investments exceed ₹250 Cr.

What Sector Metrics Matter for Dhanuka Agritech Ltd?

Sub-sector-specific signals from the latest concall — each with management's stated reason for the change

Herbicides % of Turnover

37%

QoQ +2800 bps

Why: Herbicides share increased significantly in Q3 compared to 9% in Q2.

South India Revenue Share

34%

QoQ +100 bps

Why: South India remains the largest contributing zone despite sharp demand declines.

Sales Returns (Q3)

₹72 Cr

YoY -₹2 Cr

Why: Returns were similar to last year's ₹74 Cr, primarily in the herbicide segment due to rains.

Biostimulant Regulatory Impact (9M)

₹49 Cr

Why: Regulatory changes forced a halt in sales of four biostimulant products.

Dahej Plant Revenue (Q3)

₹4 Cr

QoQ -₹18 Cr

Why: Q3 is off-season for Bifenthrin and Difenoconazole production was delayed.

Bayer Molecule Revenue (9M)

₹25-27 Cr

Why: Revenue from acquired Bayer molecules currently appearing in Dhanuka's balance sheet.

Technical Sales (Q3)

₹3-4 Cr

Why: Technical sales are not significant in the third quarter.

Cash & Liquid Investments

₹250 Cr

Why: Maintained a strong debt-free balance sheet.

What Is Dhanuka Agritech Ltd's Management Guidance?

Forward-looking targets from management for FY26

OPM Guidance

24–25%

Capex Plan

₹70 Cr

Revenue Outlook

Flattish for FY26

Margin Outlook

REAFFIRMED

Capex Plan

₹60-70 Cr

MPP-2 plant construction

Management Tone: CAUTIOUS

Guidance Changes

LOWERED

Bayer Product Revenue: ₹40 Cr → ₹30 Cr

How Fast Is Dhanuka Agritech Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue-8%+11%Inflection Down
PAT (Net Profit)-27%+12%Inflection Down
OPM14.0%-300 bpsStable

The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.

Other Deep Value Stocks in Pesticides/Agrochemicals

Heranba Industries Ltd
Very Weak
11
← Back to Pesticides/AgrochemicalsAll Deep Value SectorsDashboard

Frequently Asked Questions: Dhanuka Agritech Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What is Dhanuka Agritech Ltd's deep value score?

Dhanuka Agritech Ltd has a deep value score of 34/100 (rated Weak). This score is calculated from three components

  • Earnings Score: 15/40 — measures PAT growth momentum across quarters
  • Underperformance Score: 14/35 — how much the stock trails Nifty 500 (deeper underperformance = higher contrarian signal)
  • Quality Score: 0/25 — operational quality (margins, revenue growth, valuation)

Is Dhanuka Agritech Ltd fundamentally improving?

Dhanuka Agritech Ltd's quarterly profit (PAT) growth trajectory

  • Latest Quarter PAT Growth (QoQ): +37%
  • Previous Quarter PAT Growth (QoQ): -53%
  • 2 Quarters Ago PAT Growth (QoQ): +140%
  • PAT Acceleration: -51.6pp (profits are decelerating)
  • 1 consecutive quarters of positive PAT growth

Why is Dhanuka Agritech Ltd underperforming despite good earnings?

Dhanuka Agritech Ltd is underperforming the market despite improving earnings — this is the core deep value thesis

  • 1-Year Return vs Nifty 500: -24%
  • 6-Month Return vs Nifty 500: -9%
  • 3-Month Return vs Nifty 500: 0%
  • Yet average quarterly PAT growth is +41% — earnings are improving
  • The market often takes time to re-rate stocks with improving fundamentals. This gap between price performance and earnings improvement is what deep value research seeks to identify.

What is the earnings momentum for Dhanuka Agritech Ltd?

Dhanuka Agritech Ltd's earnings momentum is Decelerating — growth rate is slowing.

  • PAT QoQ progression: +140% → -53% → +37% (2Q ago → 1Q ago → latest)
  • Acceleration: -51.6pp
  • PAT YoY Growth: -27%

Is Dhanuka Agritech Ltd undervalued?

Dhanuka Agritech Ltd's valuation metrics

  • Price-to-Earnings (PE): 16.5x
  • Price-to-Book (PB): 3.5x
  • PEG Ratio: 1.0x
  • Margin of Safety: -52% (appears overvalued)

What are the revenue and margin trends for Dhanuka Agritech Ltd?

Dhanuka Agritech Ltd's revenue and margin trends

  • Latest Quarter Revenue Growth (QoQ): -1%
  • Average Quarterly Revenue Growth: 0%
  • Revenue Acceleration: -16.6pp
  • Latest OPM Change: +7.9pp (margins expanding)
  • Average OPM Change: +3.4pp
  • Revenue YoY: -8%

What is Dhanuka Agritech Ltd's trailing twelve month (TTM) performance?

Dhanuka Agritech Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹266 Cr
  • TTM PAT Growth: -5.3% YoY
  • TTM Revenue: ₹2,000 Cr
  • TTM Revenue Growth: +0.9% YoY
  • TTM Operating Margin: 19.7%

What sector does Dhanuka Agritech Ltd belong to?

Dhanuka Agritech Ltd key facts

  • Sector: Pesticides/Agrochemicals
  • Market Cap: ₹4.9K Cr
  • Rank in Pesticides/Agrochemicals: #1 by value score
  • Overall rank among all deep value stocks: #102

Is Dhanuka Agritech Ltd a good deep value opportunity to study?

Dhanuka Agritech Ltd shows limited deep value signals currently — score is 34/100 (Weak). Monitor for improvement.

  • Value Score: 34/100 (Weak)
  • Earnings: Not accelerating
  • 1Y Underperformance: -24% vs Nifty 500

What is the bull and bear case for Dhanuka Agritech Ltd?

Research Signals (Bull Case)

  • Operating margins expanding

Risk Factors (Bear Case)

  • Earnings growth decelerating
  • Margin pressure warning
  • Appears overvalued despite underperformance

Which other Pesticides/Agrochemicals stocks are deep value opportunities?

Other deep value stocks in Pesticides/Agrochemicals

  • Heranba Industries Ltd — Score 11/100, Very Weak

How does the Pesticides/Agrochemicals sector look for deep value?

Pesticides/Agrochemicals deep value sector overview

  • 1 deep value stocks in this sector
  • Average value score: 23/100
  • Avg PAT acceleration: -51.6pp
  • Top pick: Dhanuka Agritech Ltd

What is deep value investing?

Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.

How is the deep value score calculated?

The deep value score (0-100) combines three factors:

- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)

Higher score indicates a stronger contrarian research signal.

What are the growth catalysts for Dhanuka Agritech Ltd?

Dhanuka Agritech Ltd has 3 key growth catalysts identified from recent earnings analysis

  • New Product Or Brand Launch
  • Operating Leverage Inflection
  • Regulatory Approval Or License Win

What are the key risks in Dhanuka Agritech Ltd?

Dhanuka Agritech Ltd has 3 key risks worth monitoring

  • Significantly extended rainfall and potential El Nino impact on Kharif season
  • Ban on biostimulants led to a ₹49 Cr impact on 9-month sales
  • China ending export rebates on technicals may increase prices

What did Dhanuka Agritech Ltd's management say in the latest earnings call?

In Q3 FY26, Dhanuka Agritech Ltd's management highlighted

  • "So, first question, I think, on the PPT, you have mentioned that you're expecting a flattish revenue performance in FY '26. [Previous Revenue Growth ..."
  • "We are working for making Dahej operations EBITDA positive in FY'27 and try to reach 80% capacity utilization of the existing plant. [Initiative: Dah..."
  • "Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. [Risk (climate): HIGH]"

The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.